<html>
<head>PUBMED IDs for FBXO22</head>
<body bgcolor='#C5F0F2'><h1>FBXO22</h1><a href='https://pubmed.ncbi.nlm.nih.gov/20728256/'>Genome-wide association studies in nephrology research.</a> October 14  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20728239/'>Expression and function of miRNA in postoperative radiotherapy sensitive and resistant patients of non-small cell lung cancer.</a> August 17  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20728233/'>No association of the SUMO4 polymorphism M55V variant in type 2 diabetes in Iranian subjects.</a> February 3  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20728226/'>Aquaporin-4 water channel expression by thymoma of patients with and without myasthenia gravis.</a> October 20  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21768309/'>SCF(FBXO22) regulates histone H3 lysine 9 and 36 methylation levels by targeting histone demethylase KDM4A for ubiquitin-mediated proteasomal degradation.</a> October 25  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22761574/'>GogB is an anti-inflammatory effector that limits tissue damage during Salmonella infection through interaction with human FBXO22 and Skp1.</a> November 10  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/25336657/'>FBXO22 protein is required for optimal synthesis of the N-methyl-D-aspartate (NMDA) receptor coagonist D-serine.</a> March 4  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/28117675/'>F-Box Protein FBXO22 Mediates Polyubiquitination and Degradation of CD147 to Reverse Cisplatin Resistance of Tumor Cells.</a> April 25  2017<br></body></html>
